Zurich Insurance Group Ltd : Resistance levels that will be difficult to break
Entry price | Target | Stop-loss | Potential |
---|
CHF 257.1 |
CHF 245.2 |
CHF 259 |
+4.63% |
---|
After the strong price increase that has been seen over the past few weeks, it appears opportune to anticipate a correction phase for shares in Zurich Insurance Group Ltd, as the resistance around 257.2 CHF approaches.
Summary● The company usually posts poor financials for mid or long term investments.
● The company has poor fundamentals for a short-term investment strategy.
Strengths● The company's attractive earnings multiples are brought to light by a P/E ratio at 12.63 for the current year.
● The company is one of the best yield companies with high dividend expectations.
● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at CHF 272.1.
● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
● The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.